Real-time continuous glucose monitoring is not inferior to current standard of care for inpatient glycaemic monitoring and may decrease recurrent hypoglycaemic events

Commentary on: Spanakis EK, Urrutia A, Galindo RJ, Vellanki P, Migdal AL, Davis G, Fayfman M, Idrees T, Pasquel FJ, Coronado WZ, Albury B, Moreno E, Singh LG, Marcano I, Lizama S, Gothong C, Munir K, Chesney C, Maguire R, Scott WH, Perez-Guzman MC, Cardona S, Peng L, Umpierrez GE. Continuous Glucose Monitoring-Guided Insulin Administration in Hospitalized Patients With Diabetes: A Randomized Clinical Trial. Diabetes Care. 2022 Oct 1;45(10):2369–2375. doi: 10.2337/dc22-0716. PMID: 35984478. Implications for practice and research Continuous glucose monitoring (CGM) devices are not inferior to point-of-care capillary glucose testing for inpatient glycaemic monitoring. CGM devices could potentially reduce hypoglycaemic events in hospital, but require more research and training for acceptability in use. Context Diabetes is a common metabolic disorder, present in more than 451 million people worldwide.1 The established practice for inpatient glycaemic monitoring when an individual whose diabetes is treated...
Source: Evidence-Based Nursing - Category: Nursing Authors: Tags: Adult nursing Commentary Source Type: research